Next Article in Journal
Application of a Terephthalate and Pyrazine-Based MOF in Cr Adsorption
Previous Article in Journal
Halloysite Nanotubes Modified by Chitosan as an Efficient and Eco-Friendly Heterogeneous Nanocatalyst for the Synthesis of Heterocyclic Compounds
Open AccessAbstract

Target Misfolded Protein Clearance Pathway for Cancer Therapy

MD Anderson Cancer Center, Department of Thoracic and Cardiovascular Surgery, Houston, TX 77459, USA
Presented at the 3rd International conference on Natural Products for Cancer Prevention and Therapy, Kayseri, Turkey, 18–20 December 2019.
Proceedings 2019, 40(1), 45;
Published: 24 January 2020
The role of RNA-dependent protein kinase R (PKR) and its association with misfolded protein expression in cancer cells are unclear. Herein we report that PKR regulates misfolded protein clearance by preventing it release through exosomes and promoting lysosomal degradation of misfolded prion proteins in cancer cells. We demonstrated that PKR contributes to the lysosome function and regulates misfolded prion protein clearance. We hypothesized that PKR-associated lysosome function is critical for cancer but not normal cell survival, representing an effective approach for highly targeted cancer therapy. In screening a compound library, we identified two PKR-associated compound 1 did not affect normal cells but selectively induced cell death in cancer cells depending on their PKR expression status. Pac 1 significantly inhibited the growth of human lung and breast xenograft tumors in mice with no toxicity. Pac 1 binds to PI4K2A and disrupts the PKR/PI4K2A associated lysosome complex, contributing to destabilization of cancer cell lysosomes and triggering cell death. We observed that PKR and PI4K2A play significant prognostic roles in breast cancer patients. These results demonstrate that targeting of a PI4K2A/PKR lysosome complex may be an effective approach for cancer therapy.
Keywords: PKR; PI4K2A; lysosome; Pac 1 PKR; PI4K2A; lysosome; Pac 1
MDPI and ACS Style

Pataer, A. Target Misfolded Protein Clearance Pathway for Cancer Therapy. Proceedings 2019, 40, 45.

AMA Style

Pataer A. Target Misfolded Protein Clearance Pathway for Cancer Therapy. Proceedings. 2019; 40(1):45.

Chicago/Turabian Style

Pataer, Apar. 2019. "Target Misfolded Protein Clearance Pathway for Cancer Therapy" Proceedings 40, no. 1: 45.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop